IN2012DN02968A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN02968A IN2012DN02968A IN2968DEN2012A IN2012DN02968A IN 2012DN02968 A IN2012DN02968 A IN 2012DN02968A IN 2968DEN2012 A IN2968DEN2012 A IN 2968DEN2012A IN 2012DN02968 A IN2012DN02968 A IN 2012DN02968A
- Authority
- IN
- India
- Prior art keywords
- present
- relates
- heterocyclic
- schizophrenia
- solvate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Abstract
The present invention relates to a heterocyclic derivative of formula (I) wherein the variables are as defined in the specification or to a pharmaceutically acceptable salt or solvate thereof. The present invention further relates to pharmaceutical compositions comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of disorders mediated by nicotinic acetylcholine receptors, such as schizophrenia and Alzheimer's disease.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25110109P | 2009-10-13 | 2009-10-13 | |
EP09172872 | 2009-10-13 | ||
PCT/EP2010/065160 WO2011045258A1 (en) | 2009-10-13 | 2010-10-11 | Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN02968A true IN2012DN02968A (en) | 2015-07-31 |
Family
ID=42040651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2968DEN2012 IN2012DN02968A (en) | 2009-10-13 | 2010-10-11 |
Country Status (12)
Country | Link |
---|---|
US (1) | US8841289B2 (en) |
EP (1) | EP2488520B1 (en) |
JP (1) | JP2013507417A (en) |
KR (1) | KR20120100913A (en) |
CN (1) | CN102666540A (en) |
AU (1) | AU2010305825A1 (en) |
BR (1) | BR112012008518A2 (en) |
CA (1) | CA2776835A1 (en) |
IN (1) | IN2012DN02968A (en) |
MX (1) | MX2012004289A (en) |
RU (1) | RU2012119488A (en) |
WO (1) | WO2011045258A1 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2843383A1 (en) | 2011-07-29 | 2013-02-07 | Taisho Pharmaceutical Co., Ltd. | Amidine compound or salt thereof |
ES2611504T3 (en) | 2012-03-07 | 2017-05-09 | Institute Of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted isoquinolin-1-one compounds and their therapeutic uses |
AU2013264943B2 (en) * | 2012-05-22 | 2018-02-01 | King Abdullah University Of Science And Technology | Combination comprising parthenolide for use in the treatment of Alzheimer's Disease and other neurodegenerative disorders |
NO3044221T3 (en) | 2013-09-11 | 2018-07-21 | ||
US9617226B2 (en) | 2014-09-05 | 2017-04-11 | AbbVie Deutschland GmbH & Co. KG | Fused heterocyclic or carbocyclic compounds carrying a substituted cycloaliphatic radical and use thereof for treating vasopressin-related diseases |
CA2971413A1 (en) | 2014-12-16 | 2016-06-23 | Axovant Sciences Gmbh | Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors |
AR103297A1 (en) | 2014-12-30 | 2017-05-03 | Forma Therapeutics Inc | PIRROLO AND PIRAZOLOPIRIMIDINAS AS INHIBITORS OF THE SPECIFIC PROTEASE 7 OF UBIQUITINA |
MA41291A (en) | 2014-12-30 | 2017-11-07 | Forma Therapeutics Inc | PYRROLOTRIAZINONE AND IMIDAZOTRIAZINONE DERIVATIVES AS UBIQUE-SPECIFIC PROTEASE INHIBITORS No. 7 (USP7) FOR THE TREATMENT OF CANCER |
WO2016126926A1 (en) | 2015-02-05 | 2016-08-11 | Forma Therapeutics, Inc. | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors |
EP3253765A1 (en) | 2015-02-05 | 2017-12-13 | Forma Therapeutics, Inc. | Thienopyrimidinones as ubiquitin-specific protease 7 inhibitors |
WO2016126935A1 (en) | 2015-02-05 | 2016-08-11 | Forma Therapeutics, Inc. | Isothiazolopyrimidinones, pyrazolopyrimidinones, and pyrrolopyrimidinones as ubiquitin-specific protease 7 inhibitors |
CN106146410B (en) * | 2015-04-03 | 2018-10-12 | 中南大学 | 6- amino -4 (3H)-Quinazol derivative and its preparation method and use |
CN106279211B (en) * | 2015-06-03 | 2020-09-15 | 北京大学 | Thiazolopyrimidinone compound and preparation method and application thereof |
US10370370B2 (en) | 2015-06-10 | 2019-08-06 | Axovant Sciences Gmbh | Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors |
EP3334740A4 (en) | 2015-08-12 | 2019-02-06 | Axovant Sciences GmbH | Geminal substituted aminobenzisoxazole compounds as agonists of 7-nicotinic acetylcholine receptors |
WO2017100593A1 (en) | 2015-12-09 | 2017-06-15 | Luc Therapeutics | Thienopyrimidinone nmda receptor modulators and uses thereof |
LT3386591T (en) * | 2015-12-09 | 2020-10-12 | Cadent Therapeutics, Inc. | Heteroaromatic nmda receptor modulators and uses thereof |
EP3558318B1 (en) | 2016-12-22 | 2023-12-20 | Novartis AG | Nmda receptor modulators and uses thereof |
JOP20200338A1 (en) * | 2018-06-27 | 2020-12-24 | Reborna Biosciences Inc | Prophylactic or therapeutic agent for spinal muscular atrophy |
HU231414B1 (en) * | 2018-07-13 | 2023-08-28 | Richter Gedeon Nyrt. | Thiadiazine derivatives |
CA3102326A1 (en) | 2018-07-26 | 2020-01-30 | Domain Therapeutics | Substituted quinazolinone derivatives and their use as positive allosteric modulators of mglur4 |
CA3108519A1 (en) | 2018-08-03 | 2020-04-30 | Cadent Therapeutics, Inc. | Heteroaromatic nmda receptor modulators and uses thereof |
WO2021198191A1 (en) | 2020-03-30 | 2021-10-07 | Enyo Pharma | Quinazolinone derivatives and uses thereof for treating a cancer |
EP4126847A1 (en) | 2020-03-30 | 2023-02-08 | ENYO Pharma | Quinazolinone derivatives and uses thereof for treating a cancer |
CN112898290B (en) * | 2021-01-29 | 2022-08-05 | 中南大学 | Isoxazole formamido-4 (3H) -quinazolinone derivative and synthesis method and application thereof |
WO2024054591A1 (en) | 2022-09-07 | 2024-03-14 | Arvinas Operations, Inc. | Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0000540D0 (en) | 2000-02-18 | 2000-02-18 | Astrazeneca Ab | New compounds |
JP2005504730A (en) * | 2001-04-20 | 2005-02-17 | バーテックス ファーマシューティカルズ インコーポレイテッド | Compositions useful as GSK-3 inhibitors |
EP1472248A1 (en) * | 2002-01-17 | 2004-11-03 | Eli Lilly And Company | Modulators of acetylcholine receptors |
GB0220581D0 (en) | 2002-09-04 | 2002-10-09 | Novartis Ag | Organic Compound |
TW200536830A (en) * | 2004-02-06 | 2005-11-16 | Chugai Pharmaceutical Co Ltd | 1-(2H)-isoquinolone derivative |
RU2414467C2 (en) * | 2005-07-26 | 2011-03-20 | Санофи-Авентис | PIPERADINYL-SUBSTITUTED ISOQUINOLONE DERIVATIVES AS Rho-KINASE INHIBITORS |
ATE523500T1 (en) * | 2006-09-11 | 2011-09-15 | Organon Nv | QUINAZOLINONE AND ISOQUINOLINONE ACETAMIDE DERIVATIVES |
BRPI0720909A2 (en) * | 2006-12-27 | 2016-11-01 | Sanofi Aventis | substituted isoquinoline and isoquinolinone derivatives |
JP2010229035A (en) * | 2007-08-01 | 2010-10-14 | Taisho Pharmaceutical Co Ltd | Pyridopyrimidin-4-one derivative |
BRPI0820259A2 (en) * | 2007-11-14 | 2015-06-16 | Neurosearch As | 1,4-diaza-bicyclo [3.2.2] nonyl pyrimidine derivative, pharmaceutical composition, use of 1,4-diaza-bicyclo [3.2.2] nonyl pyrimidine derivative, and method of treating, preventing or alleviating a disease or disorder or condition of body of living animal |
CN101960691B (en) | 2008-02-29 | 2013-04-24 | 核心技术国际有限公司 | Charging device and quality judging device of pack cell |
-
2010
- 2010-10-11 AU AU2010305825A patent/AU2010305825A1/en not_active Abandoned
- 2010-10-11 US US13/501,587 patent/US8841289B2/en active Active
- 2010-10-11 CN CN2010800465507A patent/CN102666540A/en active Pending
- 2010-10-11 WO PCT/EP2010/065160 patent/WO2011045258A1/en active Application Filing
- 2010-10-11 IN IN2968DEN2012 patent/IN2012DN02968A/en unknown
- 2010-10-11 MX MX2012004289A patent/MX2012004289A/en not_active Application Discontinuation
- 2010-10-11 CA CA2776835A patent/CA2776835A1/en not_active Abandoned
- 2010-10-11 JP JP2012533593A patent/JP2013507417A/en active Pending
- 2010-10-11 BR BR112012008518A patent/BR112012008518A2/en not_active Application Discontinuation
- 2010-10-11 RU RU2012119488/04A patent/RU2012119488A/en unknown
- 2010-10-11 KR KR1020127009340A patent/KR20120100913A/en not_active Application Discontinuation
- 2010-10-11 EP EP10771062.6A patent/EP2488520B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20120100913A (en) | 2012-09-12 |
EP2488520B1 (en) | 2015-09-02 |
US20120208796A1 (en) | 2012-08-16 |
CA2776835A1 (en) | 2011-04-21 |
JP2013507417A (en) | 2013-03-04 |
RU2012119488A (en) | 2013-11-20 |
WO2011045258A1 (en) | 2011-04-21 |
CN102666540A (en) | 2012-09-12 |
US8841289B2 (en) | 2014-09-23 |
EP2488520A1 (en) | 2012-08-22 |
MX2012004289A (en) | 2012-06-12 |
BR112012008518A2 (en) | 2016-04-05 |
AU2010305825A1 (en) | 2012-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN02968A (en) | ||
WO2011051490A3 (en) | Heterocyclic derivatives | |
IN2014DN03206A (en) | ||
TN2013000285A1 (en) | Novel heterocyclic derivatives and their use in the treatment of neurological disorders | |
MX2009000531A (en) | Fused heterocyclic derivatives and methods of use. | |
MX2010007683A (en) | Fused heterocyclic derivatives and methods of use. | |
MX2014000341A (en) | Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease. | |
PH12020550503A1 (en) | Pyridine carbonyl derivatives and therapeutic uses thereof as trpc6 inhibitors | |
WO2009050242A3 (en) | Heterocycle-substituted piperazino-dihydrothienopyrimidines | |
MX2014015158A (en) | Pyridinone and pyridazinone derivatives. | |
MX2009006543A (en) | Heterocyclic compounds and their use in treating inflammation, angiogenesis and cancer. | |
MD20140059A2 (en) | Substituted 4-phenyl-pyridines for the treatment of NK-1 receptor related diseases | |
UA104489C2 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
MX2009010407A (en) | Fluorinated derivatives of deferiprone. | |
MX2009001660A (en) | 2,5-dihydroxybenzene compounds for the treatment of psoriasis. | |
WO2008023258A8 (en) | Piperidine derivatives | |
MX2010004686A (en) | Heterocyclic derivatives. | |
MX2010002900A (en) | Tricyclic heterocyclic derivatives. | |
PH12015500012A1 (en) | Benzodioxole derivative and preparation method and use thereof | |
MX2010012189A (en) | Quinuclidine derivatives as muscarinic m3 receptor antagonists. | |
MX2009007038A (en) | Isosorbide mononitrate derivatives for the treatment of intestinal disorders. | |
MX2017008495A (en) | New benzimidazole derivatives as antihistamine agents. | |
MX2009005242A (en) | 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives and therapeutic use thereof. | |
MX2009006757A (en) | 4-(heterocyclyl)alkyl-n-(arylsulfonyl) indole compounds and their use as 5-ht6 ligands. | |
PH12016500197B1 (en) | Biphenyl derivative and method for preparing same |